Thomson Medical Group warns of FY2025 loss

The decline is attributable to higher interest expenses.

Thomson Medical Group Limited (TMG) is expected to post a loss after tax for the six months ended 30 June 2025 and the full financial year, following a preliminary review of its unaudited results.

The loss is attributable to higher interest expenses from the FEMVN acquisition, cessation of projects in Singapore, and weaker performance in Malaysia, according to TMG.

The company is finalising its unaudited financial results for the period.

Meanwhile, the board has advised shareholders and investors to exercise caution when trading its securities.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia